Dementia. World Health Organisation. 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/dementia

Aarsland D, Kurz MW (2010) The epidemiology of dementia associated with parkinson disease. J Neurol Sci 289(1–2):18–22. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0022510X09008193. Cited 2024 Oct 9

Article  PubMed  Google Scholar 

Draper B, Brodaty H, Finkel SI. The IPA Complete Guides to Behavioral and Psychological Symptoms of Dementia - Specialists Guide. InternatIonal PsychogerIatrIc AssocIatIon; 2016. Available from: https://www.ipa-online.org/UserFiles/file/IPA_BPSD_Specialists_Complete_Guide_Online_2015_Final.pdf

Devshi R, Shaw S, Elliott-King J, Hogervorst E, Hiremath A, Velayudhan L et al (2015) Prevalence of behavioural and psychological symptoms of dementia in individuals with learning disabilities. Diagnostics 5(4):564–576. Available from: https://www.mdpi.com/2075-4418/5/4/564. Cited 2024 Oct 10

Article  PubMed  PubMed Central  Google Scholar 

Reus VI, Fochtmann LJ, Eyler AE, Hilty DM, Horvitz-Lennon M, Jibson MD et al (2016) The american psychiatric association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia. Am J Psychiatry 173(5):543–546. Available from: http://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2015.173501. Cited 2024 Feb 18

Article  PubMed  Google Scholar 

O’Brien JT, Holmes C, Jones M, Jones R, Livingston G, McKeith I et al (2017) Clinical practice with anti-dementia drugs: a revised (third) consensus statement from the British association for psychopharmacology. J Psychopharmacol (Oxf) 31(2):147–168. Available from: https://journals.sagepub.com/doi/10.1177/0269881116680924. Cited 2024 Oct 10

Article  Google Scholar 

Taylor DM, Barnes TR, Young AH (2021) The maudsley prescribing guidelines in psychiatry, 14th edn. John Wiley & Sons, New York, NY

Book  Google Scholar 

National Institute for Health and Care Excellence: Guidelines. London: National Institute for Health and Care Excellence (NICE). 2003. Available from: https://www.ncbi.nlm.nih.gov/books/NBK11822/. Cited 2023 Sep 12

Dementia: Assessment, management and support for people living with dementia and their carers. Vol. (NICE Guideline, No. 97.). London: National Institute for Health and Care Excellence (NICE); 2018. Available from: https://www.ncbi.nlm.nih.gov/books/NBK513207/

Quality Outcomes for People with Dementia: Building on the work of the National Dementia Strategy. Department of Health; 2010

Dyer SM, Harrison SL, Laver K, Whitehead C, Crotty M (2018) An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia. Int Psychogeriatr 30(3):295–309. Available from: https://www.cambridge.org/core/product/identifier/S1041610217002344/type/journal_article. Cited 2024 Oct 10

Article  PubMed  Google Scholar 

Husebo BS, Ballard C, Aarsland D (2011) Pain treatment of agitation in patients with dementia: a systematic review. Int J Geriatr Psychiatry 26(10):1012–1018. Available from: https://onlinelibrary.wiley.com/doi/10.1002/gps.2649. Cited 2024 Feb 1

Article  PubMed  CAS  Google Scholar 

Blytt KM, Bjorvatn B, Husebo B, Flo E (2018) Effects of pain treatment on sleep in nursing home patients with dementia and depression: a multicenter placebo-controlled randomized clinical trial. Int J Geriatr Psychiatry 33(4):663–670. Available from: https://onlinelibrary.wiley.com/doi/10.1002/gps.4839. Cited 2024 Oct 10

Article  PubMed  Google Scholar 

Dart RC, Bailey E (2007) Does therapeutic use of acetaminophen cause acute liver failure? Pharmacother J Hum Pharmacol Drug Ther 27(9):1219–1230. Available from: https://accpjournals.onlinelibrary.wiley.com/doi/10.1592/phco.27.9.1219. Cited 2024 Oct 10

Article  CAS  Google Scholar 

Brown R, Howard R, Candy B, Sampson EL (2015) Opioids for agitation in dementia. Cochrane Database Syst Rev. 2015(5):CD009705. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10964128/. Cited 2024 Dec 14

PubMed  PubMed Central  Google Scholar 

Achterberg W, Pieper MJC, Van Dalen-Kok AH, De Waal MWM, Husebo BS, Lautenbacher S, et al. Pain management in patients with dementia. Clin Interv Aging. 2013:1471. Available from: http://www.dovepress.com/pain-management-in-patients-with-dementia-peer-reviewed-article-CIA. Cited 2024 Oct 11

Moore RA, Derry S, Simon LS, Emery P (2014) Non-steroidal anti-inflammatory drugs, gastroprotection, and benefit-risk. Pain Pract 14(4):378–395. Available from: https://onlinelibrary.wiley.com/doi/10.1111/papr.12100. Cited 2024 Oct 11

Article  PubMed  Google Scholar 

van Dalen-Kok AH, Pieper MJC, de Waal MWM, Lukas A, Husebo BS, Achterberg WP (2015) Association between pain, neuropsychiatric symptoms, and physical function in dementia: a systematic review and meta-analysis. BMC Geriatr 15:49

Article  PubMed  PubMed Central  Google Scholar 

Thal LJ, Ferris SH, Kirby L, Block GA, Lines CR, Yuen E et al (2005) A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment. Neuropsychopharmacology 30(6):1204–1215. Available from: https://www.nature.com/articles/1300690. Cited 2024 Dec 18

Article  PubMed  CAS  Google Scholar 

ADAPT Research Group* (2008) Cognitive Function Over Time in the Alzheimer’s Disease Anti-inflammatory Prevention Trial (ADAPT): Results of a Randomized, Controlled Trial of Naproxen and Celecoxib. Arch Neurol. 65(7):896–905. Available from: https://doi.org/10.1001/archneur.2008.65.7.nct70006. Cited 2024 Dec 18

Article  PubMed Central  Google Scholar 

Cox-2 selective inhibitors and non-steroidal anti-inflammatory drugs (NSAIDs): Cardiovascular safety. GOV.UK. Available from: https://www.gov.uk/government/publications/cox-2-selective-inhibitors-and-non-steroidal-anti-inflammatory-drugs-nsaids-cardiovascular-safety/cox-2-selective-inhibitors-and-non-steroidal-anti-inflammatory-drugs-nsaids-cardiovascular-safety. Cited 2024 Dec 18

Rahme E, Nedjar H (2007) Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study. Rheumatology 46(3):435–438. https://doi.org/10.1093/rheumatology/kel428. Cited 2024 Dec 18

Article  PubMed  CAS  Google Scholar 

Aisen PS (2002) Evaluation of selective COX-2 inhibitors for the treatment of alzheimer’s disease. J Pain Symptom Manage 23(4):S35-40. Available from: https://www.jpsmjournal.com/article/S0885-3924%2802%2900374-3/fulltext?utm_source=chatgpt.com. Cited 2024 Dec 18

Article  PubMed  CAS  Google Scholar 

Imbimbo BP, Solfrizzi V, Panza F. Are NSAIDs useful to treat Alzheimer’s disease or mild cognitive impairment? Front Aging Neurosci. 2010;2. Available from: https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2010.00019/full. Cited 2024 Dec 18

Jordan F, Quinn TJ, McGuinness B, Passmore P, Kelly JP, Tudur Smith C et al (2020) Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia. Cochrane Database Syst Rev. 4(4):CD011459

PubMed  Google Scholar 

Derry S, Wiffen PJ, Häuser W, Mücke M, Tölle TR, Bell RF, et al. Oral non-steroidal anti-inflammatory drugs for fibromyalgia in adults. Cochrane Pain, Palliative and Supportive Care Group, editor. Cochrane Database Syst Rev. 2017;2020(2). Available from: http://doi.wiley.com/10.1002/14651858.CD012332.pub2. Cited 2024 Oct 11

Finkel SI (2004) Effects of rivastigmine on behavioral and psychological symptoms of dementia in Alzheimer’s disease. Clin Ther 26(7):980–990. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0149291804901725. Cited 2024 Oct 10

Article  PubMed  CAS  Google Scholar 

Herrmann N, Rabheru K, Wang J, Binder C (2005) Galantamine treatment of problematic behavior in alzheimer disease: post-hoc analysis of pooled data from three large trials. Am J Geriatr Psychiatry 13(6):527–534. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1064748112614444. Cited 2024 Oct 10

Article  PubMed  Google Scholar 

Lockhart IA, Orme ME, Mitchell SA (2011) The efficacy of licensed-indication use of donepezil and memantine monotherapies for treating behavioural and psychological symptoms of dementia in patients with alzheimer’s disease: systematic review and meta-analysis. Dement Geriatr Cogn Disord Extra 1(1):212–227. Available from: https://karger.com/DEE/article/doi/10.1159/000330032. Cited 2024 Oct 10

Article  CAS  Google Scholar 

Rodda J, Morgan S, Walker Z (2009) Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer’s disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine. Int Psychogeriatr 21(05):813. Available from: http://www.journals.cambridge.org/abstract_S1041610209990354. Cited 2024 Oct 10

Article  PubMed  Google Scholar 

Battle CE, Abdul-Rahim AH, Shenkin SD, Hewitt J, Quinn TJ. Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis. Cochrane Dementia and Cognitive Improvement Group, editor. Cochrane Database Syst Rev. 2021;2021(2). Available from: http://doi.wiley.com/10.1002/14651858.CD013306.pub2. Cited 2024 Oct 10

Fox C, Crugel M, Maidment I, Auestad BH, Coulton S, Treloar A et al (2012) Efficacy of memantine for agitation in alzheimer’s dementia: a randomised double-blind placebo controlled trial. Breitner JCS, editor. PLoS One. 7(5):e35185. Available from: https://dx.plos.org/10.1371/journal.pone.0035185. Cited 2024 Oct 10

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bandeen-Roche K, Seplaki CL, Huang J, Buta B, Kalyani RR, Varadhan R et al (2015) Frailty in older adults: a nationally representative profile in the United States. J Gerontol A Biol Sci Med Sci 70(11):1427–1434. Available from: https://academic.oup.com/biomedgerontology/article-lookup/doi/10.1093/gerona/glv133. Cited 2024 Oct 10

Article  PubMed  PubMed Central  Google Scholar 

Díaz-Gutiérrez MJ, Martínez-Cengotitabengoa M, De Sáez Adana E, Cano AI, Martínez-Cengotitabengoa MT, Besga A et al (2017) Relationship between the use of benzodiazepines and falls in older adults: a systematic review. Maturitas. 101:17–22. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0378512217304784. Cited 2024 Oct 10

Article  PubMed  Google Scholar 

Reddy MSS, Achary U, Harbishettar V, Sivakumar PT, Varghese M (2018) Paradoxical reaction to benzodiazepines in elderly – Case series. Asian J Psychiatry 35:8–10. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1876201818303265. Cited 2024 Oct 10

Article  Google Scholar 

Richelson E (1997) Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs. Mayo Clin Proc 72(9):835–847. Available from: https://linkinghub.elsevier.com/retrieve/pii/S002561961163499X. Cited 2024 Oct 10

Article  PubMed